A recent investigation has brought to light the troubling prevalence of illegal weight loss drug sales in the United Kingdom, with certain businesses exploiting online review platforms such as Trustpilot
All posts tagged in weight-loss drugs
13Articles
In a landmark development underscoring the global race for obesity treatments, US pharmaceutical giant Pfizer has secured a ten billion dollar takeover of Metsera. The deal follows an intense bidding
The powerful Novo Nordisk Foundation, the largest shareholder in pharmaceutical giant Novo Nordisk, has executed a dramatic boardroom takeover after a sharp disagreement about the company’s strategic direction. The move,
Weight loss medications, specifically GLP1 agonists like Ozempic Wegovy and Mounjaro, are redefining the landscape of healthcare in Britain, with new research signposting not only longer lives for millions but
A major rise in the cost of Mounjaro is set to impact more than a million weight loss patients across Britain next month amid an international dispute over medicine prices.
British supermarkets are experiencing their first decline in grocery sales volumes this year, with experts attributing part of this downturn to the rising popularity of weight-loss medications. Market research firm
Danish pharmaceutical giant Novo Nordisk has projected reduced growth for 2025 amidst mounting competition in the weight-loss drugs market from American rivals. The company, renowned for its obesity treatments Ozempic
The surging popularity of weight-loss medications is creating unprecedented ripples across the alcohol industry, with major beverage companies facing potential long-term revenue challenges. Investment heavyweight Terry Smith’s recent divestment from
Novo Nordisk, the Danish pharmaceutical powerhouse, has invested hundreds of thousands of pounds in sponsorship deals with major UK pharmacy chains, including Boots and Lloyds, to enhance sales of its
The aggressive marketing of weight-loss injections to British consumers has sparked significant concern amongst healthcare experts, who are witnessing what they describe as a “wild west” approach to pharmaceutical promotion.
The United Kingdom’s weight-loss medication market has witnessed an unprecedented surge, with more than 500,000 individuals now utilising revolutionary anti-obesity drugs Mounjaro and Wegovy. This dramatic increase has occurred within
Groundbreaking research indicates that popular weight-loss medications like Ozempic, Wegovy, and Mounjaro might have far-reaching applications beyond obesity treatment, potentially revolutionising the approach to various chronic conditions. Dr Mo Sarhan,
In a remarkable feat, Eli Lilly’s weight-loss drug Zepbound has surpassed 1 billion in sales for the first time, exceeding Wall Street’s expectations. The American pharmaceutical giant also saw strong
